Purchase Order 75F40126P00209

The Drug Enforcement Administration awarded a purchase order to Cayman Chemical Co Inc. for $42,870.00 on July 28, 2026, with ultimate completion on August 31, 2026. The order is firm fixed price and carries no set-aside. Work is performed in Ann Arbor, Michigan. The purchase order procures pharmacological testing compounds, consistent with the vendor's role as a specialized supplier of controlled-substance reference materials and synthetic compounds to federal law enforcement and health...

The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $35,150.00 firm fixed-price purchase order contract to Purisys LLC, a for-profit limited liability company. The contract is for the delivery of 7-hydroxy-cannabidiol and 7-carboxy-cannabidiol, which are likely cannabinoid compounds. The contract has a total small business set-aside designation, indicating it was reserved for small business concerns. The period of performance runs from the award date of...

This is a $38,450.00 firm fixed price purchase order awarded by the Drug Enforcement Administration (DEA) to Cayman Chemical Co Inc., a for-profit manufacturer of biochemical products and research tools. The purchase order is for 8 substances and has a completion date of June 27, 2024. Cayman Chemical is a major supplier of reference materials, analytical standards, and specialized reagents to federal agencies for drug enforcement, public health, and biomedical research. The company has...

The U.S. Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $1,330,000.00 firm fixed price definitive contract to Cayman Chemical Co Inc., a for-profit manufacturer of biochemicals, assay kits, and medical supplies located in Ann Arbor, Michigan. The contract is for the delivery of opioid detection kits to support the CDC's public health initiatives related to the opioid epidemic. Cayman Chemical has also provided controlled substance standards...

This is a firm-fixed price BPA call order awarded by the Defense Health Agency (DHA) to Cayman Chemical Co Inc., a leading manufacturer of biochemical products and research tools. The contract, valued at $11,540.48, is for the delivery of drug standards to be used for drug screening and evaluation testing of service member specimens. Cayman Chemical has an established track record of providing reference materials, analytical standards, and specialized reagents to support federal agencies' drug...

The Defense Logistics Agency awarded a $2,699.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 28, 2026, for 60 milliliters of Epidiolex 100 mg/ml solution. Epidiolex is an FDA-approved cannabidiol medication used primarily for the treatment of seizure disorders. The award is non-competitive and represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through...

The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for Epidiolex 100 mg/ml oral solution with a ceiling value of $1,280.92 and a firm fixed price. This delivery order, valued below $1,300, represents a single transaction under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government. The contract is non-set-aside and was competitively awarded, with performance scheduled for completion by...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Epidiolex 100 mg/ml solution in 60 ml packs at a ceiling value of $1,349.88. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The award is expected to be completed by December 10, 2025, with performance originating from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...

The Defense Logistics Agency (DLA) awarded a $5,319.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of Epidiolex 100 mg/ml solution in 100-milliliter packs, with a completion date of February 10, 2026. This delivery order was awarded competitively with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Epidiolex is an FDA-approved cannabidiol-based medication used primarily for the...

The Defense Logistics Agency awarded a $3,720.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 milliliters of Epidiolex 100 mg/ml solution on November 5, 2025, with completion targeted for November 28, 2025. This is a non-set-aside delivery order issued against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be performed at the company's...